Skip to Content

LCE 50 (Stalevo 50 12.5 mg / 200 mg / 50 mg)

Generic Name: carbidopa/entacapone/levodopa

Pill with imprint LCE 50 is Brown, Round and has been identified as Stalevo 50 12.5 mg / 200 mg / 50 mg. It is supplied by Novartis Pharmaceuticals.

Stalevo 50 is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Stalevo 50 12.5 mg / 200 mg / 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LCE 50

Stalevo 50

Generic Name:
carbidopa/entacapone/levodopa
Imprint:
LCE 50
Strength:
12.5 mg / 200 mg / 50 mg
Color:
Brown
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals
Inactive Ingredients:
corn starch
croscarmellose sodium
glycerin
hypromelloses
magnesium stearate
mannitol
polysorbate 80
povidone
sucrose
ferric oxide red
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00781-5613 Sandoz Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide